Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. - Wikidata - awgldk - TriplyDB

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

http://www.wikidata.org/entity/Q42111827

about

Treating BCG-induced disease in children Treatments for BCG-induced disease in children Admixed phylogenetic distribution of drug resistant Mycobacterium tuberculosis in Saudi Arabia A Case of Bacillus Calmette-Guérin Cystitis Diagnosed with a Novel Loop-mediated Isothermal Amplification Method.Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency.Clinical and laboratory observation of Bacillus Calmette-Guérin infections.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guérin Treatment for Bladder Cancer Tuberculosis in infants: a retrospective study in China.BCG immunotherapy for bladder cancer--the effects of substrain differences.Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect.Globalization of pediatric transplantation: The risk of tuberculosis or not tuberculosis.Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy.Thr270Ile in embC (Rv3793) is not a marker for ethambutol resistance in the Mycobacterium tuberculosis complex.Rifampin-resistant Mycobacterium bovis BCG-induced disease in HIV-infected infant, Vietnam.Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death.Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus.Metabolic Activity Interferometer: A Powerful Tool for Testing Antibiotics

P2860

Q24201807-CA96AF4D-2ED1-4FB1-B58A-D3B86200A3DB Q24239915-910DEE10-5A78-4FAC-ABEF-58FEAD32D5BF Q28485907-9343F841-5034-4FEA-B4C5-3ECA844ADEB9 Q33869646-12ADC511-2840-4007-8131-D078EE19DB6A Q34542530-8197E192-CEC4-4328-9C54-DB342E713985 Q35246507-E18EE481-9680-4C2A-88D7-99ED7120D538 Q35450383-C21A633C-C959-48E6-B81A-B2BF8AF9DD28 Q35959145-D2B25FEF-4DAB-42D2-BAE8-71AD85532286 Q36396241-C2D5B57D-19B5-4233-BF5E-992BCD236DF1 Q36472378-BB7ADCD7-D3B7-4376-A7BF-F649CDEBEBEA Q36845115-F666FF8B-3EF6-4471-92E0-F40F22B99067 Q38138412-5208223C-6AA2-4667-9D35-9D30D94EABE3 Q38843500-1763951F-62A7-4683-B212-9B3D95416972 Q38979616-169FE512-39EA-4A2E-B8D5-6748D0BF490B Q40598734-C231B0A8-2ACF-4951-96A2-AFA2BAA1B56D Q42706352-393E8F58-DF22-4011-89BF-7DA08BE8724E Q43088221-9BB52F91-3B76-40F9-BA2C-6F96F990723C Q46524797-A645F29B-E3B3-4813-A40A-1B49B04E8496 Q50072876-8ADA84E3-5E2F-4851-816D-B58EECA640C4 Q58911119-803015A2-2FBF-42D2-BD72-616CB2F6FFF5

P2860

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

http://www.wikidata.org/entity/Q42111827

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@en

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@nl

type

label

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@en

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@nl

prefLabel

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@en

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@nl

P1433

Q42111827-8FB6E840-020B-4F63-A76F-8CB47010F438

P1476

Q42111827-A07B1620-080E-413C-9306-9D57C255A2C0

P2093

Q42111827-02CDA709-87CA-42D3-B066-1BB36E23274E

Q42111827-B41E5CD7-1F77-4121-B751-62AA8F6E7ADF

Q42111827-C08FE2BC-BADD-4105-A598-D256F4D8B15D

P2860

Q42111827-139E1130-F685-4F85-A21C-1DBA2289BE9E

Q42111827-2B3A25D9-E6DC-44B7-AB44-87C0F3ADDD12

Q42111827-2E514CF4-C7C5-4991-A3D9-120F186A0B2F

Q42111827-521FE020-C894-4CE1-AE18-72FFE3C3303B

Q42111827-74C9D256-51DE-4374-A4C7-E4C5D5462125

Q42111827-7EBFC4D7-C35C-49F1-9F02-BB8E7B532964

Q42111827-80A6B6FD-35D9-42B3-9F67-494008766DB7

Q42111827-86E43F9E-92FA-48B2-A8E7-653EB045F080

Q42111827-9893584A-277F-4AF6-A6A8-55D40FD775CE

Q42111827-A4E4B0C7-7E80-4FB0-BE9F-AD033BA78AD3

P304

Q42111827-BF5BD3F6-FA3F-4A85-B688-B227F6CAFB23

P31

Q42111827-B1FE15C2-D1C7-491D-93A8-15BC9E7E8440

P356

Q42111827-AD1E9464-044C-44E9-9F2D-95D38B489F9C

P407

Q42111827-00E5CD8A-EEBC-42E8-B792-07FC44C07CBC

P433

Q42111827-1BBC5FA9-3296-4FCC-A725-716C1AC2B7D2

P478

Q42111827-8AB89AA0-344E-4D8D-BEA9-2FCA4E81C2DA

P50

Q42111827-77D96C8A-8940-4B01-901C-473C08FB631E

Q42111827-A7D2335A-11FC-4488-9376-545989D9FE57

Q42111827-E9FC0DCD-300A-4148-A63E-6A142139C058

P577

Q42111827-575EE2E9-35C8-4917-9D24-DD050979A635

P5875

Q42111827-D0B901B8-5A6D-4DF8-A28E-BCED2BC11E5F

P698

Q42111827-356C05D2-2198-46D3-8B71-CC5D096D1C74

P921

Q42111827-CF7F2F47-9D73-4BC6-AC16-12225754EC75

P932

Q42111827-DF0285A1-BDA3-4C3B-87EF-9746DF39587F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

@en

P2093

Aina Sievers

http://www.w3.org/2001/XMLSchema#string

Marc Tebruegge

http://www.w3.org/2001/XMLSchema#string

Tom G Connell

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4

In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis

Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

Comparative genomics of BCG vaccines by whole-genome DNA microarray

Influence of BCG vaccine strain on the immune response and protection against tuberculosis.

Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.

Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.

Making BCG vaccination programmes safer in the HIV era.

Isoniazid pharmacokinetics in children treated for respiratory tuberculosis

P304

316-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01302-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Roy M Robins-Browne

P577

2008-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23423295

http://www.w3.org/2001/XMLSchema#string

P698

18955515

http://www.w3.org/2001/XMLSchema#string

P921

P932

2612166

http://www.w3.org/2001/XMLSchema#string